HEALTH / FITNESS NEWS
August 07, 2012 12:00:00 AM
  Follow @ Twitter

Pfizer and Johnson & Johnson have given up tests of a new therapy to treat Alzheimer's disease, saying the treatment did not measure up to expectations.

The final, phase 3 trial of the intravenous bapineuzumab therapy did not meet targets for effectiveness in aiding cognitive and functional performance of Alzheimer's victims, according to the two drug giants.

As a result, they decided to end the program to develop the treatment, they said.

"We are obviously very disappointed in the outcomes of this trial. We are also saddened by the lost opportunity to provide a meaningful advance for patients afflicted with mild-to-moderate Alzheimer's disease and their caregivers," said Steven Romano, senior vice president at Pfizer Inc.

"Yet these data, and the subgroup and biomarker analyses under way, will further inform our understanding of this complex disease and advance research in this field."

AFP

 


PREVIOUS STORY
UN keeps tab on Philippine birth control debate
NEXT STORY
Mexico destroys 8 mn chickens amid bird flu outbreak

Bookmark and Share
   




FIJI NEWS
Aussie actress weds at Turtle IslandOne of Australia's favourite small-screen actresses reportedly tied the knot in Fiji early this month.
SPORTS
Suva ends 38-year Sangam IDC droughtSuva's 38-year wait to lift the Sangam Inter District Championship title ended at Lawaqa Park this evening as the Whites defeated Rifle Range 1-0 in the grand final.
LIFESTYLE/FASHION
Blake chase Ms World for FijiMiss World Fiji Director Andhy Blake is adamant to select the best contestants with a view to win Fiji the coveted Miss World crown.
ENTERTAINMENT
Sam Smithís debut In The Lonely Hour out in MayBRIT and BBC Sound Poll winner Sam Smithís debut album In The Lonely Hour is out on May 23.
OFFBEAT
Mercury 'took Princess Diana to gay barQueen singer Freddie Mercury disguised the late Princess Diana as a male model and smuggled her into a notorious gay bar, according to a memoir serialised in Britain's Sunday Times.
NEWS SPORTS INFOTAINMENT SERVICES MOBILE EXTRA HOT TOPICS